InsidersTradesSigma
Discover the full record of transactions filed by 전교중, Président. Officer active across 2 companies, notably 지투지바이오. In total, 1 filings have been published. The latest transaction was disclosed on 27 March 2026 — Purchase. Regulator: DART (FSS). All data is free.
1 of 1 declaration
Jeon Kyo-jung is the Chairman of G2G Bio, a company specializing in biotechnology. In this role, he oversees strategic direction and the development of new products. G2G Bio is recognized for its innovations in the biotechnology field.